GSK Finds a Buyer in Omega Pharma for its Non-Core OTC Brands in Europe
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 24 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1703 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
GlaxoSmithKline (GSK) has agreed to divest its non-core European OTC brands to Omega Pharma for €470 M (US$614 M) in order to streamline its consumer healthcare business...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS